Literature DB >> 12727931

Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.

Taizo Wada1, Akihiro Konno, Shepherd H Schurman, Elizabeth K Garabedian, Stacie M Anderson, Martha Kirby, David L Nelson, Fabio Candotti.   

Abstract

Revertant mosaicism due to true back mutations or second-site mutations has been identified in several inherited disorders. The occurrence of revertants is considered rare, and the underlying genetic mechanisms remain mostly unknown. Here we describe somatic mosaicism in two brothers affected with Wiskott-Aldrich syndrome (WAS). The original mutation causing disease in this family is a single base insertion (1305insG) in the WAS protein (WASP) gene, which results in frameshift and abrogates protein expression. Both patients, however, showed expression of WASP in a fraction of their T cells that were demonstrated to carry a second-site mutation causing the deletion of 19 nucleotides from nucleotide 1299 to 1316. This deletion abrogated the effects of the original mutation and restored the WASP reading frame. In vitro expression studies indicated that mutant protein encoded by the second-site mutation was expressed and functional, since it was able to bind to cellular partners and mediate T cell receptor/CD3 downregulation. These observations were consistent with evidence of in vivo selective advantage of WASP-expressing lymphocytes. Molecular analysis revealed that the sequence surrounding the deletion contained two 4-bp direct repeats and that a hairpin structure could be formed by five GC pairs within the deleted fragment. These findings strongly suggest that slipped mispairing was the cause of this second-site mutation and that selective accumulation of WASP-expressing T lymphocytes led to revertant mosaicism in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727931      PMCID: PMC154438          DOI: 10.1172/JCI15485

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation.

Authors:  O Parolini; S Berardelli; E Riedl; C Bello-Fernandez; H Strobl; O Majdic; W Knapp
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

2.  Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.

Authors:  F Candotti; F Facchetti; L Blanzuoli; D M Stewart; D L Nelson; R M Blaese
Journal:  Gene Ther       Date:  1999-06       Impact factor: 5.250

Review 3.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion.

Authors:  M F Jonkman; H Scheffer; R Stulp; H H Pas; M Nijenhuis; K Heeres; K Owaribe; L Pulkkinen; J Uitto
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

Review 5.  The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.

Authors:  S B Snapper; F S Rosen
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.

Authors:  T N Darling; C Yee; J W Bauer; H Hintner; K B Yancey
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

7.  Development of improved adenosine deaminase retroviral vectors.

Authors:  M Onodera; D M Nelson; A Yachie; G J Jagadeesh; B A Bunnell; R A Morgan; R M Blaese
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 8.  Trinucleotide repeat DNA structures: dynamic mutations from dynamic DNA.

Authors:  C E Pearson; R R Sinden
Journal:  Curr Opin Struct Biol       Date:  1998-06       Impact factor: 6.809

9.  Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism.

Authors:  Q Waisfisz; N V Morgan; M Savino; J P de Winter; C G van Berkel; M E Hoatlin; L Ianzano; R A Gibson; F Arwert; A Savoia; C G Mathew; J C Pronk; H Joenje
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

10.  Structural and functional basis for JAK3-deficient severe combined immunodeficiency.

Authors:  F Candotti; S A Oakes; J A Johnston; S Giliani; R F Schumacher; P Mella; M Fiorini; A G Ugazio; R Badolato; L D Notarangelo; F Bozzi; P Macchi; D Strina; P Vezzoni; R M Blaese; J J O'Shea; A Villa
Journal:  Blood       Date:  1997-11-15       Impact factor: 22.113

View more
  23 in total

Review 1.  Revertant mosaicism in skin: natural gene therapy.

Authors:  Joey E Lai-Cheong; John A McGrath; Jouni Uitto
Journal:  Trends Mol Med       Date:  2010-12-29       Impact factor: 11.951

Review 2.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

3.  Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa.

Authors:  Anna M G Pasmooij; Hendri H Pas; Franciska C L Deviaene; Miranda Nijenhuis; Marcel F Jonkman
Journal:  Am J Hum Genet       Date:  2005-09-09       Impact factor: 11.025

4.  Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray.

Authors:  D K Bayer; C A Martinez; H S Sorte; L R Forbes; G J Demmler-Harrison; I C Hanson; N M Pearson; L M Noroski; S R Zaki; W J Bellini; M S Leduc; Y Yang; C M Eng; A Patel; O K Rodningen; D M Muzny; R A Gibbs; I M Campbell; C A Shaw; M W Baker; V Zhang; J R Lupski; J S Orange; F O Seeborg; A Stray-Pedersen
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 5.  WASP: a key immunological multitasker.

Authors:  Adrian J Thrasher; Siobhan O Burns
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

Review 6.  Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.

Authors:  Fabio Candotti
Journal:  Int J Hematol       Date:  2014-02-01       Impact factor: 2.490

7.  Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells.

Authors:  Marie Pouzolles; Alice Machado; Mickaël Guilbaud; Magali Irla; Sarah Gailhac; Pierre Barennes; Daniela Cesana; Andrea Calabria; Fabrizio Benedicenti; Arnauld Sergé; Indu Raman; Quan-Zhen Li; Eugenio Montini; David Klatzmann; Oumeya Adjali; Naomi Taylor; Valérie S Zimmermann
Journal:  J Allergy Clin Immunol       Date:  2019-09-09       Impact factor: 10.793

8.  Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells.

Authors:  Alexander Astrakhan; Hans D Ochs; David J Rawlings
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

9.  Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome.

Authors:  Brian R Davis; Michael J Dicola; Nicole L Prokopishyn; Jonathan B Rosenberg; Daniele Moratto; Linda M Muul; Fabio Candotti; R Michael Blaese
Journal:  Blood       Date:  2008-03-10       Impact factor: 22.113

10.  A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Authors:  Taco W Kuijpers; Ester M M van Leeuwen; Barbara H Barendregt; Paul Klarenbeek; Daan J aan de Kerk; Paul A Baars; Machiel H Jansen; Niek de Vries; René A W van Lier; Mirjam van der Burg
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.